Background In non-small cell lung cancer (NSCLC), there may be a relationship between
programmed death-ligand 1 (PD-L1) expression, driver mutations and cigarette smoking …

Objectives It was reported that programmed cell death-ligand 1 (PD-L1) expression is
associated with smoking and wild-type epidermal growth factor receptor (EGFR) in lung …

Background The aim of the study was to assess programmed death‐ligand‐1 (PD‐L1)
expression in different histological types and gene mutation status of patients with non‐small …

We aimed to evaluate whether different driver mutations have varying impacts on the
programmed cell death-ligand 1 (PD-L1) expression of non-small cell lung cancer (NSCLC) …

Background Programmed death ligand‐1 (PD‐L1) expression is a well‐known predictive
biomarker of response to immune checkpoint blockade in non‐small cell lung cancer …

Background This multicenter, retrospective study explored the value of oncogene driver
subtype, programmed death‐1 ligand (PD‐L1) status, and smoking status for predicting …

Purpose The study aimed to evaluate the clinicopathological and molecular profiles
associated with programmed death ligand 1 (PD-L1) expression in non-small cell lung cell …

Introduction The clinicopathological features of carcinomas expressing programmed death
ligand 1 (PD-L1) and their associations with common driver mutations, such as mutations in …

Background Smoking histories are independently associated with poor response to
epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) in non-small cell …

Objectives Programmed death-ligand 1 (PD-L1) expression is a predictive biomarker of
response to immunotherapies targeting programmed death-1/PD-L1 in advanced-stage lung …